Suvretta Capital Management, LLC Molecular Partners Ag Transaction History
Suvretta Capital Management, LLC
- $2.4 Billion
- Q4 2024
A detailed history of Suvretta Capital Management, LLC transactions in Molecular Partners Ag stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 2,221,494 shares of MOLN stock, worth $10.9 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
2,221,494
Previous 400,000
455.37%
Holding current value
$10.9 Million
Previous $2.04 Million
418.27%
% of portfolio
0.44%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
3.58MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA1.35MShares$6.63 Million0.24% of portfolio
-
Ubs Group Ag6.87KShares$33,6720.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,7980.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,3180.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $159M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...